Works matching IS 07423071 AND DT 2017 AND VI 34 AND IP 2

Results: 27

Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial ( BOOST® T1).

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 167, doi. 10.1111/dme.13068

By:

Hirsch, I. B.;
Franek, E.;
Mersebach, H.;
Bardtrum, L.;
Hermansen, K.

Publication type:

Article

Insulin degludec/insulin aspart once daily in Type 2 diabetes: a comparison of simple or stepwise titration algorithms ( BOOST®: SIMPLE USE).

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 174, doi. 10.1111/dme.13069

By:

Park, S. W.;
Bebakar, W. M. W.;
Hernandez, P. G.;
Macura, S.;
Hersløv, M. L.;
Rosa, R.

Publication type:

Article

Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 229, doi. 10.1111/dme.13082

By:

Abu‐Ashour, W.;
Chibrikova, L.;
Midodzi, W. K.;
Twells, L. K.;
Gamble, J.‐M.

Publication type:

Article

Sex-specific incidence rates and risk factors of insulin resistance and β-cell dysfunction: a decade follow-up in a Middle Eastern population.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 245, doi. 10.1111/dme.13117

By:

Derakhshan, A.;
Tohidi, M.;
Hajebrahimi, M. A.;
Saadat, N.;
Azizi, F.;
Hadaegh, F.

Publication type:

Article

Diagnostic performance of HbA1c for diabetes in Arab vs. European populations: a systematic review and meta-analysis.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 156, doi. 10.1111/dme.13118

By:

Bertran, E. A.;
Berlie, H. D.;
Taylor, A.;
Divine, G.;
Jaber, L. A.

Publication type:

Article

Dissecting heterogeneity in paediatric Type 1 diabetes: association of TCF7L2 rs7903146 TT and low-risk human leukocyte antigen (HLA) genotypes.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 286, doi. 10.1111/dme.13123

By:

Redondo, M. J.;
Grant, S. F. A.;
Davis, A.;
Greenbaum, C.

Publication type:

Article

Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 180, doi. 10.1111/dme.13125

By:

Kumar, S.;
Jang, H. C.;
Demirağ, N. G.;
Skjøth, T. V.;
Endahl, L.;
Bode, B.

Publication type:

Article

Impact of a multifaceted strategy to improve perioperative diabetes care.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 278, doi. 10.1111/dme.13130

By:

Hommel, I.;
Wollersheim, H.;
Tack, C. J.;
Mulder, J.;
Gurp, P. J.;
Hulscher, M. E. J. L.

Publication type:

Article

Sitagliptin plus pantoprazole can restore but not maintain insulin independence after clinical islet transplantation: results of a pilot study.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 204, doi. 10.1111/dme.13131

By:

Senior, P. A.;
Koh, A.;
Yau, J.;
Imes, S.;
Dinyari, P.;
Malcolm, A. J.;
Light, P.;
Shapiro, A. M. J.

Publication type:

Article

Brain natriuretic peptide and insulin resistance in older adults.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 235, doi. 10.1111/dme.13139

By:

Kim, F.;
Biggs, M. L.;
Kizer, J. R.;
Brutsaert, E. F.;
Filippi, C.;
Newman, A. B.;
Kronmal, R. A.;
Tracy, R. P.;
Gottdiener, J. S.;
Djoussé, L.;
Boer, I. H.;
Psaty, B. M.;
Siscovick, D. S.;
Mukamal, K. J.

Publication type:

Article

Effectiveness of intensification therapies in Danes with Type 2 diabetes who use basal insulin: a population-based study.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 213, doi. 10.1111/dme.13168

By:

Thomsen, R. W.;
Baggesen, L. M.;
Søgaard, M.;
Pedersen, L.;
Nørrelund, H.;
Buhl, E. S.;
Haase, C. L.;
Johnsen, S. P.

Publication type:

Article

Insulin resistance and β-cell function in smokers: results from the EGIR- RISC European multicentre study.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 223, doi. 10.1111/dme.13172

By:

Gottsäter, M.;
Balkau, B.;
Hatunic, M.;
Gabriel, R.;
Anderwald, C.‐H.;
Dekker, J.;
Lalic, N.;
Nilsson, P. M.

Publication type:

Article

Elevated 12-hydroxyeicosatetraenoic acid (12- HETE) levels in serum of individuals with newly diagnosed Type 1 diabetes.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 292, doi. 10.1111/dme.13177

By:

Hennessy, E.;
Rakovac Tisdall, A.;
Murphy, N.;
Carroll, A.;
O'Gorman, D.;
Breen, L.;
Clarke, C.;
Clynes, M.;
Dowling, P.;
Sreenan, S.

Publication type:

Article

Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 197, doi. 10.1111/dme.13185

By:

Shomali, M. E.;
Ørsted, D. D.;
Cannon, A. J.

Publication type:

Article

Barriers to and enablers of insulin self-titration in adults with Type 2 diabetes: a qualitative study.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 253, doi. 10.1111/dme.13196

By:

McBain, H.;
Begum, S.;
Rahman, S.;
Mulligan, K.

Publication type:

Article

Table of Contents 1.

Published in:: Diabetic Medicine, 2017, v. 34, n. 2, p. 141, doi. 10.1111/dme.13210
Publication type:: Article

Table of Contents 2.

Published in:: Diabetic Medicine, 2017, v. 34, n. 2, p. 143, doi. 10.1111/dme.13211
Publication type:: Article

Aims and Scope.

Published in:: Diabetic Medicine, 2017, v. 34, n. 2, p. 144, doi. 10.1111/dme.13212
Publication type:: Article

Editorial Board.

Published in:: Diabetic Medicine, 2017, v. 34, n. 2, p. 145, doi. 10.1111/dme.13213
Publication type:: Article

Safety and efficacy of insulin degludec/liraglutide ( IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 189, doi. 10.1111/dme.13256

By:

Rodbard, H. W.;
Bode, B. W.;
Harris, S. B.;
Rose, L.;
Lehmann, L.;
Jarlov, H.;
Thurman, J.

Publication type:

Article

Use of antibiotics in childhood and risk of Type 1 diabetes: a population-based case-control study.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 272, doi. 10.1111/dme.13262

By:

Mikkelsen, K. H.;
Knop, F. K.;
Vilsbøll, T.;
Frost, M.;
Hallas, J.;
Pottegård, A.

Publication type:

Article

Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 262, doi. 10.1111/dme.13268

By:

Kropff, J.;
DeJong, J.;
Favero, S.;
Place, J.;
Messori, M.;
Coestier, B.;
Farret, A.;
Boscari, F.;
Galasso, S.;
Avogaro, A.;
Bruttomesso, D.;
Cobelli, C.;
Renard, E.;
Magni, L.;
DeVries, J. H.

Publication type:

Article

Circulating adiponectin concentration is inversely associated with glucose tolerance and insulin secretion in people with newly diagnosed diabetes.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 239, doi. 10.1111/dme.13278

By:

Weber, K. S.;
Strassburger, K.;
Pacini, G.;
Nowotny, B.;
Müssig, K.;
Szendroedi, J.;
Herder, C.;
Roden, M.

Publication type:

Article

Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 291, doi. 10.1111/dme.13279

By:

Schütz‐Fuhrmann, I.;
Castañeda, J.;
Reznik, Y.;
Aronson, R.;
Conget, I.;
Liabat, S.;
Runzis, S.;
Portu, S.;
Cohen, O.

Publication type:

Article

Vitamin C deficiency and diabetes mellitus - easily missed?

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 294, doi. 10.1111/dme.13287

By:

Christie‐David, D. J.;
Gunton, J. E.

Publication type:

Article

Trials of new anti-diabetes agents.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 147, doi. 10.1111/dme.13306

By:

Holt, R. I. G.

Publication type:

Article

RD Lawrence Lecture 2015 Old habits are hard to break: lessons from the study of hypoglycaemia.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 148, doi. 10.1111/dme.13277

By:

McCrimmon, R. J.

Publication type:

Article

Works matching IS 07423071 AND DT 2017 AND VI 34 AND IP 2

Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial ( BOOST<sup>®</sup> T1).

Insulin degludec/insulin aspart once daily in Type 2 diabetes: a comparison of simple or stepwise titration algorithms ( BOOST<sup>®</sup>: SIMPLE USE).

Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study.

Sex-specific incidence rates and risk factors of insulin resistance and β-cell dysfunction: a decade follow-up in a Middle Eastern population.

Diagnostic performance of HbA<sub>1c</sub> for diabetes in Arab vs. European populations: a systematic review and meta-analysis.

Dissecting heterogeneity in paediatric Type 1 diabetes: association of TCF7L2 rs7903146 TT and low-risk human leukocyte antigen (HLA) genotypes.

Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study.

Impact of a multifaceted strategy to improve perioperative diabetes care.

Sitagliptin plus pantoprazole can restore but not maintain insulin independence after clinical islet transplantation: results of a pilot study.

Brain natriuretic peptide and insulin resistance in older adults.

Effectiveness of intensification therapies in Danes with Type 2 diabetes who use basal insulin: a population-based study.

Insulin resistance and β-cell function in smokers: results from the EGIR- RISC European multicentre study.

Elevated 12-hydroxyeicosatetraenoic acid (12- HETE) levels in serum of individuals with newly diagnosed Type 1 diabetes.

Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials.

Barriers to and enablers of insulin self-titration in adults with Type 2 diabetes: a qualitative study.

Table of Contents 1.

Table of Contents 2.

Aims and Scope.

Editorial Board.

Safety and efficacy of insulin degludec/liraglutide ( IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial.

Use of antibiotics in childhood and risk of Type 1 diabetes: a population-based case-control study.

Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial.

Circulating adiponectin concentration is inversely associated with glucose tolerance and insulin secretion in people with newly diagnosed diabetes.

Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial.

Vitamin C deficiency and diabetes mellitus - easily missed?

Trials of new anti-diabetes agents.

RD Lawrence Lecture 2015 Old habits are hard to break: lessons from the study of hypoglycaemia.